FDA fast-tracked more MIT-born biotechs than industry average, study finds
“...it’s clear that MIT is creating innovative therapeutics on a regular basis.”
“...it’s clear that MIT is creating innovative therapeutics on a regular basis.”
“It would not shock me if the transition eventually starts accelerating."
Dushyant Shahrawat (SF '15) writes: "New marketplaces are enabling a broad range of assets to start getting traded...”
"With misinformation rising...we may not have the right tools to keep the state in check. Yet we do not have the luxury not to try."
Why policy should be part of your net-zero climate strategy
Trade group titans clash on climate policy
Zeynep Ton and Sarah Kalloch on the benefit for workers and businesses when they streamline their product offerings.
"Ethics assumes networks of relationships...This idea of empathy underpins everything when we talk about ethics."
"The hack of SolarWinds Corp…is the latest episode in a continuing game known as the 'side-door hack.’"
...experts see a likelihood that if Mr. Gensler is confirmed...the SEC could return to large, headline-making fines against private equity.